IRIS - Res&Arch Institutional Research Information System - Research & Archive

GRESELE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.129
EU - Europa 9.975
AS - Asia 9.798
SA - Sud America 1.733
Continente sconosciuto - Info sul continente non disponibili 864
AF - Africa 241
OC - Oceania 11
Totale 38.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.529
SG - Singapore 4.324
IE - Irlanda 1.691
UA - Ucraina 1.655
HK - Hong Kong 1.641
IT - Italia 1.607
RU - Federazione Russa 1.445
BR - Brasile 1.260
CN - Cina 1.191
VN - Vietnam 1.011
SE - Svezia 805
DE - Germania 719
FR - Francia 624
FI - Finlandia 510
GB - Regno Unito 349
KR - Corea 287
CA - Canada 271
TR - Turchia 271
BD - Bangladesh 239
IN - India 180
AR - Argentina 151
IQ - Iraq 93
PL - Polonia 81
MX - Messico 79
CO - Colombia 78
NL - Olanda 75
JP - Giappone 73
VE - Venezuela 67
ZA - Sudafrica 67
ES - Italia 64
EC - Ecuador 62
PK - Pakistan 61
UZ - Uzbekistan 60
CH - Svizzera 59
AT - Austria 58
ID - Indonesia 56
SA - Arabia Saudita 50
BE - Belgio 47
CR - Costa Rica 45
PH - Filippine 38
CL - Cile 34
LB - Libano 34
NI - Nicaragua 34
MA - Marocco 33
TT - Trinidad e Tobago 32
MY - Malesia 31
PY - Paraguay 26
CZ - Repubblica Ceca 23
JM - Giamaica 23
LT - Lituania 23
GT - Guatemala 22
SV - El Salvador 22
BO - Bolivia 21
EG - Egitto 21
GR - Grecia 21
TN - Tunisia 21
CW - ???statistics.table.value.countryCode.CW??? 20
HN - Honduras 20
JO - Giordania 20
KE - Kenya 20
RO - Romania 19
AE - Emirati Arabi Uniti 15
IL - Israele 15
UY - Uruguay 15
KZ - Kazakistan 14
MK - Macedonia 14
AL - Albania 13
DZ - Algeria 13
EU - Europa 13
PE - Perù 13
PR - Porto Rico 12
SC - Seychelles 11
AZ - Azerbaigian 10
GP - Guadalupe 10
IR - Iran 10
NP - Nepal 10
OM - Oman 10
RS - Serbia 10
TH - Thailandia 10
BG - Bulgaria 9
PS - Palestinian Territory 9
EE - Estonia 8
HU - Ungheria 8
ET - Etiopia 7
PA - Panama 7
PT - Portogallo 7
AU - Australia 6
DK - Danimarca 6
BH - Bahrain 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
LY - Libia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
CU - Cuba 4
GA - Gabon 4
GD - Grenada 4
KW - Kuwait 4
Totale 37.831
Salva come PNG Salva come JPEG
Città #
Singapore 2.894
Chandler 1.786
Dublin 1.678
Hong Kong 1.637
San Jose 1.486
Ashburn 1.186
San Mateo 907
Jacksonville 903
Santa Clara 602
Council Bluffs 548
Boardman 534
Moscow 484
Dong Ket 467
Altamura 434
Princeton 427
Medford 416
Lauterbourg 390
Perugia 351
Lawrence 312
Wilmington 292
Beijing 276
Seoul 267
Ann Arbor 265
Des Moines 230
Los Angeles 222
Andover 211
New York 202
Izmir 193
Munich 192
Ho Chi Minh City 191
The Dalles 170
Saint Petersburg 139
Hanoi 120
São Paulo 119
Piscataway 113
Helsinki 96
Dallas 88
Rome 84
Turku 80
Norwalk 77
Tokyo 70
Montreal 69
Phoenix 67
Orem 66
Frankfurt am Main 64
North Bergen 63
Brooklyn 61
Denver 57
Shanghai 57
Atlanta 56
Houston 55
Redmond 55
Dearborn 54
London 54
Chicago 53
Woodbridge 52
Toronto 51
Milan 46
San Paolo di Civitate 46
Brussels 45
Rio de Janeiro 41
Johannesburg 40
Baghdad 39
Warsaw 39
Nuremberg 38
San José 38
San Diego 36
Stockholm 36
Buffalo 35
Brasília 32
Chennai 32
Managua 32
San Francisco 32
Da Nang 31
Tashkent 31
Amsterdam 30
Belo Horizonte 29
Poplar 27
Naples 26
Columbus 25
Falkenstein 25
Ankara 23
Manchester 23
Mexico City 23
Ottawa 23
Charlotte 22
Curitiba 22
Porto Alegre 22
Quito 22
Guayaquil 21
Boston 20
Washington 20
Willemstad 20
Den Haag 19
Dhaka 19
Florence 19
Medellín 19
Philadelphia 19
San Salvador 19
Campinas 18
Totale 23.297
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 536
PIASTRINE TRASFETTATE CON MATERIALE GENETICO ESOGENO E MICROPARTICELLE DERIVATE DA DETTE PIASTRINE TRASFETTATE, METODO PER LA LORO PREPARAZIONE E LORO USI. 282
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 195
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 191
Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestring the liberated arachidonic acid in the extracellular space 161
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. 160
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 158
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 154
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 153
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. 152
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 151
Impact of Chronic Antiplatelet Therapy prior to Hospitalization on Ischemic and Bleeding Events in Invasively Managed Patients with Acute Coronary Syndromes: The ACUITY Trial 150
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 147
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 147
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. 145
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 145
Beta 1-tubulin in human platelets: not simply a structural cell frame. 143
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 141
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 139
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 139
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 137
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 137
Nitric oxide and its antithrombotic action on the cardiovascular system 135
Platelets are essential for leukocyte recruitment in allergic inflammation. 135
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 134
Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA) 134
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 133
Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination 133
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 132
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 131
Effect of substituted stilbenes on platelet function 130
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 130
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 130
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 128
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 128
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 128
Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: Meta-Analysis of 119 clinical trials involving 100 667 patients 128
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 127
Allergen induces the migration of platelets to lung tissue in allergic asthma. 127
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 127
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 126
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 126
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 125
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 124
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 124
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 122
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 120
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 120
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 120
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. 120
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 120
Effect of First Long-Term Training on Whole Blood Count and Blood Clotting Parameters in Thoroughbreds 120
Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs 120
The european hematology association roadmap for european hematology research: A consensus document 119
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 118
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 118
Tardive gestosis: clinical observations. 118
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 117
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 117
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 117
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders 117
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 116
Choline plasmalogen biosynthesis by transmethylation in human platelets 116
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 115
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 114
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 114
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 113
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. 113
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 113
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 112
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 111
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. 111
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 111
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 111
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 111
Anti-platelet treatments in cancer: Basic and clinical research 111
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression: a marker of platelet activation 110
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 110
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 110
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity 109
Selective cytochrome c displacement by phosphate and Ca2+ in brain mitochondria 109
Anti-platelet therapy: phosphodiesterase inhibitors. 109
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 109
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data 109
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry 109
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET 109
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 109
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 107
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 107
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. 107
Arterite temporale occulta: contributo casistico e revisione della letteratura 107
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits 107
Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. 107
[Occult temporal arteritis. Case reports and review of the literature]. 107
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers 107
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 106
Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2. 106
Active secretion of lysosomal glycohydrolases by activated human platelets “in vivo” studies on lysosomal release and molecular mechanisms regulating their secretion 106
Carotid plaque detection improves the predictve value of CHA 2 DS 2 -VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 106
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. 106
Totale 13.021
Salva come PNG Salva come JPEG
Categoria #
all - tutte 179.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.412 0 0 0 129 104 22 37 998 43 113 416 550
2022/20235.964 462 1.152 97 451 461 684 6 253 2.128 19 161 90
2023/20242.648 138 203 121 41 29 13 1.019 52 220 99 412 301
2024/20255.200 55 556 145 195 684 241 188 409 1.195 311 791 430
2025/202611.391 819 737 604 1.493 1.632 984 2.039 470 1.229 876 353 155
2026/20273.676 197 366 703 2.410 0 0 0 0 0 0 0 0
Totale 38.751